HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Derya Tilki Selected Research
Derya Tilki Research Topics
Disease
176
Prostatic Neoplasms (Prostate Cancer)
12/2022 - 08/2008
109
Neoplasms (Cancer)
09/2022 - 12/2004
45
Carcinoma (Carcinomatosis)
01/2022 - 01/2010
38
Urinary Bladder Neoplasms (Bladder Cancer)
09/2022 - 12/2004
36
Neoplasm Metastasis (Metastasis)
03/2022 - 02/2010
23
Margins of Excision
01/2022 - 08/2008
13
Lymphatic Metastasis
01/2021 - 09/2009
9
Renal Cell Carcinoma (Grawitz Tumor)
01/2022 - 08/2009
7
Urinary Incontinence
01/2022 - 01/2017
5
Obesity
01/2021 - 02/2013
5
Carcinoma in Situ
11/2011 - 09/2008
3
Kidney Neoplasms (Kidney Cancer)
06/2022 - 01/2021
3
Urinary Bladder Neck Obstruction (Bladder Neck Obstruction)
11/2021 - 12/2007
3
Adenocarcinoma
01/2021 - 03/2012
3
Erectile Dysfunction
01/2021 - 01/2017
3
Infections
11/2019 - 11/2009
3
Pathologic Constriction (Stenosis)
10/2019 - 04/2010
3
Thrombosis (Thrombus)
01/2018 - 02/2015
3
Transitional Cell Carcinoma
07/2011 - 12/2004
3
Prostatic Hyperplasia (Benign Prostatic Hyperplasia)
04/2010 - 03/2009
2
Squamous Cell Carcinoma (Epidermoid Carcinoma)
01/2021 - 01/2019
2
Circulating Neoplastic Cells
01/2021 - 12/2017
2
Vascular Remodeling
03/2012 - 11/2007
1
Urachal cancer
01/2022
1
Urethral Neoplasms (Urethral Cancer)
01/2021
1
Disease Progression
01/2021
1
Neuroendocrine Carcinoma
01/2021
1
COVID-19
01/2021
1
Postoperative Pain
06/2020
1
Pain (Aches)
06/2020
Drug/Important Bio-Agent (IBA)
36
Prostate-Specific Antigen (Semenogelase)
IBA
02/2022 - 12/2010
14
Antigens
IBA
01/2022 - 01/2018
13
Androgens
IBA
03/2022 - 04/2014
11
Hormones (Hormone)
IBA
01/2022 - 12/2016
6
Biomarkers (Surrogate Marker)
IBA
01/2022 - 11/2005
5
Docetaxel (Taxotere)
FDA Link
01/2022 - 01/2019
4
gallium 68 PSMA-11
IBA
12/2021 - 08/2020
4
Dihydrotachysterol (AT 10)
IBA
10/2021 - 11/2013
4
CEACAM1 Protein
IBA
07/2010 - 12/2004
3
Ligands
IBA
01/2022 - 04/2014
3
Indicators and Reagents (Reagents)
IBA
10/2019 - 08/2010
3
Androgen Receptors (Androgen Receptor)
IBA
05/2019 - 04/2014
3
Endostatins
IBA
06/2012 - 07/2006
3
Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)
IBA
03/2012 - 12/2004
3
Angiogenesis Inhibitors
IBA
05/2009 - 07/2006
2
abiraterone
IBA
01/2022 - 01/2022
2
enzalutamide
IBA
01/2022 - 12/2020
2
Androgen Antagonists (Antiandrogens)
IBA
01/2021 - 08/2020
2
Abiraterone Acetate
IBA
01/2021 - 08/2020
2
Carcinoembryonic Antigen
IBA
07/2010 - 12/2007
2
Cell Adhesion Molecule-1
IBA
07/2010 - 12/2007
2
Orosomucoid (Seromucoid)
IBA
11/2009 - 11/2005
1
Dronabinol (THC)
FDA Link
Generic
09/2022
1
Elements
IBA
04/2022
1
COVID-19 Vaccines
IBA
01/2022
1
177Lu-PSMA-617
IBA
01/2022
1
Lutetium-177
IBA
01/2022
1
darolutamide
IBA
01/2022
1
Aligeron (AS 2)
IBA
01/2022
1
N-acetyltalosaminuronic acid (NAT)
IBA
01/2022
1
Tumor Biomarkers (Tumor Markers)
IBA
01/2022
1
apalutamide
IBA
01/2022
1
68Ga-DOTAGA-(3-iodo-y)fk(Sub-KuE)
IBA
12/2021
1
Immune Checkpoint Inhibitors
IBA
10/2021
1
Globulins
IBA
09/2021
1
Serum Albumin
IBA
09/2021
1
Selenium
IBA
09/2021
1
Vitamin D
FDA Link
Generic
09/2021
1
Prostaglandins G
IBA
09/2021
1
2-methylcyclopentadienyl manganese tricarbonyl (MMT)
IBA
01/2021
1
3,10-dibromofascaplysin
IBA
12/2020
1
Pharmaceutical Preparations
IBA
12/2020
1
Alkaloids
IBA
12/2020
1
1,2- di- (4- sulfamidophenyl)- 4- butylpyrazolidine- 3,5- dione (DSB)
IBA
08/2020
1
DNA (Deoxyribonucleic Acid)
IBA
08/2020
Therapy/Procedure
131
Prostatectomy (Retropubic Prostatectomy)
12/2022 - 08/2008
56
Therapeutics
03/2022 - 12/2004
55
Cystectomy
09/2022 - 08/2008
45
Radiotherapy
10/2022 - 04/2015
41
Lymph Node Excision (Lymph Node Dissection)
01/2022 - 01/2011
17
Castration
01/2022 - 04/2014
15
Drug Therapy (Chemotherapy)
01/2022 - 09/2010
14
Nephrectomy
06/2022 - 08/2009
9
Adjuvant Chemotherapy
05/2015 - 06/2010
8
Thrombectomy
06/2022 - 09/2014
7
Neoadjuvant Therapy
02/2022 - 09/2010
6
Length of Stay
02/2022 - 08/2015
5
Brachytherapy
03/2022 - 04/2015
4
Catheters
11/2021 - 10/2013
4
Solid-State Lasers
11/2021 - 04/2010
2
Adjuvant Radiotherapy
01/2022 - 01/2022
2
Aftercare (After-Treatment)
01/2022 - 09/2017
2
Salvage Therapy
11/2021 - 12/2017
2
Operative Time
11/2015 - 12/2010
2
Laser Therapy (Surgery, Laser)
11/2011 - 09/2010
2
Semiconductor Lasers
03/2009 - 12/2007
1
Blood Transfusion (Blood Transfusions)
11/2021
1
Immunotherapy
10/2021
1
Pelvic Exenteration
07/2021
1
Minimally Invasive Surgical Procedures
06/2020